These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11433688)

  • 1. [Thalidomide and thrombosis: three observations].
    Pouaha J; Martin S; Trechot P; Truchetet F; Barbaud A; Schmutz JL
    Presse Med; 2001 Jun; 30(20):1008-9. PubMed ID: 11433688
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thalidomide and thrombosis].
    Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
    Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide: focus on its employment in rheumatologic diseases.
    Ossandon A; Cassarà EA; Priori R; Valesini G
    Clin Exp Rheumatol; 2002; 20(5):709-18. PubMed ID: 12412207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thalidomide: the revival].
    Grosbois B; Duguet C
    Rev Med Interne; 2001 Jan; 22(1):5-7. PubMed ID: 11218298
    [No Abstract]   [Full Text] [Related]  

  • 5. [Weight gain during treatment with thalidomide: a case report].
    Comte H; Béné J; Auffret M; Gautier S; Salle-Staumont D
    Therapie; 2014; 69(5):457-9. PubMed ID: 25285366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thalidomide in treatment of connective diseases and vasculities].
    Maruotti N; Cantatore FP; Ribatti D
    Reumatismo; 2006; 58(3):187-90. PubMed ID: 17013434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al.
    Gompel A; Frances C; Piette JC; Blanc AS; Cordoliani F; Piette AM
    Arthritis Rheum; 1999 Oct; 42(10):2259-60. PubMed ID: 10524707
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recurrent aphthosis: safety of low dose thalidomide].
    Gil H; Perrin S; Dupond JL; Meaux-Ruault N; Hafsaoui C; Limat S; Magy-Bertrand N
    Rev Med Interne; 2010 Jun; 31(6):403-5. PubMed ID: 20430488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide: dermatological indications, mechanisms of action and side-effects.
    Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
    Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar Langerhans cell histiocytosis and thalidomide: an effective treatment option.
    Ruiz Beguerie J; Fernández J; Stringa MF; Anaya J
    Int J Dermatol; 2017 Mar; 56(3):324-326. PubMed ID: 27778317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thalidomide--a new prospective therapy in rheumatology and transplantation].
    Pałgan K; Pałgan I; Dziedziczko A
    Wiad Lek; 2003; 56(11-12):574-6. PubMed ID: 15058168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on immunosuppressive therapy.
    Singer NG; McCune WJ
    Curr Opin Rheumatol; 1998 May; 10(3):169-73. PubMed ID: 9608317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thalidomide in adult multisystem Langerhans cell histiocytosis: a case report].
    Alioua Z; Hjira N; Oumakhir S; Frikh R; Ghfir M; Rimani M; Sedrati O
    Rev Med Interne; 2006 Aug; 27(8):633-6. PubMed ID: 16631279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient secondary amenorrhea in women treated by thalidomide.
    Frances C; El Khoury S; Gompel A; Bécherel PA; Chosidow O; Piette JC
    Eur J Dermatol; 2002; 12(1):63-5. PubMed ID: 11809598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide induces amenorrhea in patients with lupus disease.
    Ordi J; Cortes F; Martinez N; Mauri M; De Torres I; Vilardell M
    Arthritis Rheum; 1998 Dec; 41(12):2273-5. PubMed ID: 9870886
    [No Abstract]   [Full Text] [Related]  

  • 16. Thalidomide and its dermatologic uses.
    Moraes M; Russo G
    Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbation of psoriasis by thalidomide in Behçet's syndrome.
    Dobson CM; Parslew RA
    Br J Dermatol; 2003 Aug; 149(2):432-3. PubMed ID: 12932265
    [No Abstract]   [Full Text] [Related]  

  • 18. Should we screen patients for inherited thrombophilia before starting thalidomide?
    Otrock ZK; Mahfouz RA; El-Hajj II; Harb MI; Sawaya RA
    Am J Clin Oncol; 2006 Feb; 29(1):100-1. PubMed ID: 16462512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressant drugs in dermatology (author's transl)].
    Christeler A; Delacrétaz J
    Ther Umsch; 1979 May; 36(5):456-62. PubMed ID: 451959
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide therapy for juvenile-onset entero-Behçet disease.
    Yasui K; Misawa Y; Shimizu T; Komiyama A; Kawakami T; Mizoguchi M
    J Pediatr; 2003 Nov; 143(5):692-4. PubMed ID: 14649666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.